Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Balanced salt solution versus human albumin for AKI in end-stage liver disease (non-inferiority)
ChiCTR2000034544Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of albumin (human) in acute kidney failure (AKF) (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Renal function reverse rate on day 7. Started Jul 2020; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR2000034544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034544.